Press:
- Novartis's asthma drug wins EU approval for usage in children
- European CHMP issues positive opinion on extension of indication for omalizumab (Xolair ®)
- Xolair (Omalizumab) shows promise in treating allergic asthma inadequately controlled by inhaled corticosteroid
- Real Patient Stories
- Will Xolair Become Obsolete in the Treatment of Allergies?
- Next-Generation Xolair (omalizumab) sounds pretty good
- Xolair Gets 'Black Box' Warning